Analyze Diet
Journal of veterinary pharmacology and therapeutics2014; 38(3); 301-304; doi: 10.1111/jvp.12192

Pharmacokinetics and physiologic effects of alprazolam after a single oral dose in healthy mares.

Abstract: The objective of this study was to evaluate the pharmacokinetic properties and physiologic effects of a single oral dose of alprazolam in horses. Seven adult female horses received an oral administration of alprazolam at a dosage of 0.04 mg/kg body weight. Blood samples were collected at various time points and assayed for alprazolam and its metabolite, α-hydroxyalprazolam, using liquid chromatography/mass spectrometry. Pharmacokinetic disposition of alprazolam was analyzed by a one-compartmental approach. Mean plasma pharmacokinetic parameters (±SD) following single-dose administration of alprazolam were as follows: Cmax 14.76 ± 3.72 ng/mL and area under the curve (AUC0-∞ ) 358.77 ± 76.26 ng·h/mL. Median (range) Tmax was 3 h (1-12 h). Alpha-hydroxyalprazolam concentrations were detected in each horse, although concentrations were low (Cmax 1.36 ± 0.28 ng/mL). Repeat physical examinations and assessment of the degree of sedation and ataxia were performed every 12 h to evaluate for adverse effects. Oral alprazolam tablets were absorbed in adult horses and no clinically relevant adverse events were observed. Further evaluation of repeated dosing and safety of administration of alprazolam to horses is warranted.
Publication Date: 2014-11-27 PubMed ID: 25427652DOI: 10.1111/jvp.12192Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research focused on studying the pharmacokinetic properties (how a drug is absorbed, distributed, metabolized, and excreted in the body) and physiological effects of a one-time oral dose of alprazolam in horses. The outcomes show that the drug was absorbed by the horses’ bodies and caused no observable adverse effects, suggesting further exploration of its safe use is needed.

Study Design

  • The study involved seven healthy, fully grown female horses.
  • Each horse was given a single oral dose of alprazolam (known as an anti-anxiety medicine in humans) at a dosage tailored to their body weight (0.04mg per kilogram).
  • The team then sampled the horses’ blood at different times to measure the levels of alprazolam and one of its metabolites, α-hydroxyalprazolam.
  • To determine these levels, the researchers used a technique called liquid chromatography/mass spectrometry, which separates the components of a substance and measures their relative concentration.

Findings

  • The study’s results were analyzed using a ‘one-compartmental approach,’ which assumes the body as a single, uniform entity for drug distribution.
  • Key measurements taken included the ‘maximum concentration’ (Cmax), ‘time to reach maximum concentration’ (Tmax), and total amount of drug in the body over time, also measured as ‘area under the curve’ (AUC).
  • The average Cmax for alprazolam was found to be 14.76 ± 3.72 ng/mL, with an average AUC of 358.77 ± 76.26 ng·h/mL. The median Tmax (time it took to reach this concentration in blood) was 3 hours, although it varied between 1-12 hours.
  • The researchers also found α-hydroxyalprazolam in every horse, yet at low levels.

Physical Examination and Adverse Effects

  • To assess any side effects, repeating physical examinations and evaluation of sedation and ataxia (loss of coordination) were performed every 12 hours.
  • No clinically significant adverse effects were detected, indicating that the horses tolerated the drug well.

Conclusion

  • The research concluded that the alprazolam tablets taken orally were absorbed into the body of adult horses, with no significant adverse effects.
  • However, it recommends further study for repeated dosing and the safety of administering alprazolam to horses.

Cite This Article

APA
Wong DM, Davis JL, Alcott CJ, Hepworth-Warren KL, Galow-Kersh NL, Rice S, Coetzee JF. (2014). Pharmacokinetics and physiologic effects of alprazolam after a single oral dose in healthy mares. J Vet Pharmacol Ther, 38(3), 301-304. https://doi.org/10.1111/jvp.12192

Publication

ISSN: 1365-2885
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 38
Issue: 3
Pages: 301-304

Researcher Affiliations

Wong, D M
  • Department of Veterinary Clinical Sciences, Lloyd Veterinary Medical Center, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
Davis, J L
    Alcott, C J
      Hepworth-Warren, K L
        Galow-Kersh, N L
          Rice, S
            Coetzee, J F

              MeSH Terms

              • Administration, Oral
              • Alprazolam / administration & dosage
              • Alprazolam / analogs & derivatives
              • Alprazolam / blood
              • Alprazolam / pharmacokinetics
              • Alprazolam / pharmacology
              • Animals
              • Ataxia / chemically induced
              • Ataxia / veterinary
              • Conscious Sedation / methods
              • Conscious Sedation / veterinary
              • Female
              • Horses / metabolism
              • Hypnotics and Sedatives / administration & dosage
              • Hypnotics and Sedatives / blood
              • Hypnotics and Sedatives / pharmacokinetics
              • Hypnotics and Sedatives / pharmacology

              Citations

              This article has been cited 1 times.
              1. Davis JL, Schirmer J, Medlin E. Pharmacokinetics, pharmacodynamics and clinical use of trazodone and its active metabolite m-chlorophenylpiperazine in the horse. J Vet Pharmacol Ther 2018 Jun;41(3):393-401.
                doi: 10.1111/jvp.12477pubmed: 29333613google scholar: lookup